• Author: Bryant R. England
Clear all

Changes in patterns of use of advanced therapies following emerging data about adverse events in patients with rheumatoid arthritis from the Veterans Affairs health system

Abstract: Objective: To determine whether prescribing practices for Janus kinase inhibitors (JAKi), tumor necrosis factor inhibitors (TNFi), and non-TNFi biologic agents changed …

Lowering expectations: glucocorticoid tapering among Veterans with rheumatoid arthritis achieving low disease activity on stable biologic therapy

Abstract: Objective: In the Steroid EliMination In Rheumatoid Arthritis (SEMIRA) trial, 65% of patients with rheumatoid arthritis (RA) in low disease activity (LDA) on stable …

A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis

Codebeautify.org Text to HTML Converter Abstract: To examine temporal trends in all-cause and cause-specific mortality in patients with rheumatoid arthritis (RA) in the Veterans …

The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease

Abstract: To determine whether RA and interstitial lung disease (ILD) severity measures are associated with survival in patients with RA-ILD. We studied US veterans with RA-ILD …

Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid Arthritis

Abstract: Objective: To determine the association of inhalant exposures with rheumatoid arthritis (RA)–related autoantibodies and severity in US veterans. Methods: Participants …